Next Generation Bioproduction
Disruptive Bioeconomy
In its strategic area, acib creates the basis for a disruptive bioeconomy along two main strategic high-risk thrusts that go beyond the state of research: CO2/H2-based bioeconomy and the supply of essential medicines through bioproduction in plant cells.
- Complete process technologies for large-scale production of food-and-feed products and biodegradable materials based on (waste) CO2 feedstock utilization by microbial gas fermentation
- Light-driven conversion of CO2 for specific production purposes
- Plant biotechnology for the future production of medicines
- Revolutionized production of metabolites from medicinal plants (e.g. opiates for pain therapy)
- Decentralized production of biopharmaceuticals
Renewable Resources
The Renewable Resources Area is mainly dealing with the industrial sectors of food and animal feed as well as materials, both of which have to solve important issues relating to the circular economy and resource efficiency.
- Improved agricultural production systems by microbiome functions
- Modular bioprocessing for (oligo)saccharide and C- and N-glycoside production
- Meat aroma for alternative protein food ingredients
- Novel functionalization of bio-based and biodegradable materials
- Closing the recycling loop for textiles and bio-based plastics
Sustainable Production
The Sustainable Production Area exploits novel strategies in bioproduction with the overarching aim to increase sustainability. Specifically, Sustainable Production utilises next-generation microbial cell factories and advanced biocatalysis in technologically feasible and environmentally friendly processes, and addresses various aspects of eco-friendly biomanufacturing and green chemistry.
- Innovative multistep-enzymatic cascade reactions
- Sustainable technologies for yeast-based recombinant protein production
- Microbial biotechnology and Synthetic Biology of yeast, bacteria and filamentous fungi
- Modular process development for peptides, aroma compounds, agrochemicals, components of energy storage
- Use of climate friendly substrates and valorization of waste streams
Health Biotechnology
The focus of the Health Biotechnology Area is on the development of production processes, the molecular characterization of novel biopharmaceutical products and the identification of new active pharmaceutical ingredients (API). In addition, the development of early diagnosis systems will enable a shift towards early prophylactic medical measures.
Testing corona drugs on SARS-CoV-2 virus samples
Fermenting futures, yeast from an art perspective
Valuable proteins from CO2
Hope in the fight against global droughts
The COMET funding program
Interested in joining the COMET network?
Projects for and with company partners. At the moment all funding has been exhausted. However, any interested company from small to large and from Austria to international can express their interest to be put on the waiting list. Martin Trinker will be happy to advise you and to answer all of your questions.
